Publish
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify Identity
Community
Support
About
Terms
Privacy
Issues
Docs
Paper
Log in
Sign up
Paper
0
Paper
Conversation
Grants
Reviews
Document
Submit new version
Download
Flag content
0
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study
Internal Medicine
Surgery
Pulmonary And Respiratory Medicine
Show More
Authors
Bo Noordman
,
Manon Spaander
Roelf Valkema
,
Bas Wijnhoven
,
Mark Henegouwen
,
Joël Shapiro
,
Katharina Biermann
,
Ate Gaast
,
Richard Hillegersberg
,
Maarten Hulshof
,
Kausilia Krishnadath
,
Sjoerd Lagarde
,
Grard Nieuwenhuijzen
,
Liekele Oostenbrug
,
Peter Siersema
,
Erik Schoon
,
Meindert Sosef
,
Ewout Steyerberg
,
J. Lanschot
,
Michael Doukas
,
Nanda Krak
,
Jan‐Werner Poley
,
Caroline Rij
,
Jaques Bergman
,
Suzanne Gisbertz
,
Hanneke Laarhoven
,
Sybren Meijer
,
Lucas Goense
,
Nadia Mohammad
,
Monique Hobbelink
,
G. Offerhaus
,
Frank Vleggaar
,
Wouter Curvers
,
Geert‐Jan Creemers
,
Mark Roef
,
Maurice Sangen
,
Jeroen Buijsen
,
Robert Riedl
,
Wendy Schreurs
,
Fabienne Warmerdam
,
MJR Janssen
,
Chella Post
,
Sandra Radema
,
Camiel Rosman
+42 authors
,
Heidi Rütten
Journal
The Lancet Oncology
Published
Jun 1, 2018
DOI
10.1016/s1470-2045(18)30201-8
Show more
Save
Tip
Document
Submit new version
Download
Flag content
0
Tip
Save
Document
Submit new version
Download
Flag content
Paper
Conversation
Grants
Reviews